Utah Medical Products, Inc. (FRA:UTM)

Utah Medical Products Statistics

Total Valuation

FRA:UTM has a market cap or net worth of EUR 152.01 million. The enterprise value is 79.73 million.

Market Cap	152.01M
Enterprise Value	79.73M

Important Dates

The next estimated earnings date is Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Sep 17, 2025

Share Statistics

Current Share Class	3.20M
Shares Outstanding	n/a
Shares Change (YoY)	-7.79%
Shares Change (QoQ)	-1.19%
Owned by Insiders (%)	7.14%
Owned by Institutions (%)	63.79%
Float	2.77M

Valuation Ratios

The trailing PE ratio is 15.35.

PE Ratio	15.35
Forward PE	n/a
PS Ratio	4.62
PB Ratio	1.51
P/TBV Ratio	1.73
P/FCF Ratio	12.85
P/OCF Ratio	12.60
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.72, with an EV/FCF ratio of 6.74.

EV / Earnings	8.05
EV / Sales	2.40
EV / EBITDA	5.72
EV / EBIT	7.02
EV / FCF	6.74

Financial Position

The company has a current ratio of 32.06, with a Debt / Equity ratio of 0.00.

Current Ratio	32.06
Quick Ratio	29.22
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.02
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 9.59% and return on invested capital (ROIC) is 6.79%.

Return on Equity (ROE)	9.59%
Return on Assets (ROA)	6.56%
Return on Invested Capital (ROIC)	6.79%
Return on Capital Employed (ROCE)	11.10%
Revenue Per Employee	204,515
Profits Per Employee	61,524
Employee Count	167
Asset Turnover	0.31
Inventory Turnover	1.92

Taxes

In the past 12 months, FRA:UTM has paid 2.55 million in taxes.

Income Tax	2.55M
Effective Tax Rate	20.50%

Stock Price Statistics

The stock price has decreased by -21.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.67%
50-Day Moving Average	49.61
200-Day Moving Average	49.21
Relative Strength Index (RSI)	44.07
Average Volume (20 Days)	0

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	11.73

Income Statement

In the last 12 months, FRA:UTM had revenue of EUR 32.93 million and earned 9.91 million in profits. Earnings per share was 3.01.

Revenue	32.93M
Gross Profit	18.80M
Operating Income	11.25M
Pretax Income	12.46M
Net Income	9.91M
EBITDA	13.75M
EBIT	11.25M
Earnings Per Share (EPS)	3.01

Balance Sheet

The company has 71.82 million in cash and 205,404 in debt, giving a net cash position of 71.62 million.

Cash & Cash Equivalents	71.82M
Total Debt	205,404
Net Cash	71.62M
Net Cash Per Share	n/a
Equity (Book Value)	100.79M
Book Value Per Share	31.45
Working Capital	79.71M

Cash Flow

In the last 12 months, operating cash flow was 12.06 million and capital expenditures -230,973, giving a free cash flow of 11.83 million.

Operating Cash Flow	12.06M
Capital Expenditures	-230,973
Free Cash Flow	11.83M
FCF Per Share	n/a

Margins

Gross margin is 57.10%, with operating and profit margins of 34.18% and 30.08%.

Gross Margin	57.10%
Operating Margin	34.18%
Pretax Margin	37.84%
Profit Margin	30.08%
EBITDA Margin	41.75%
EBIT Margin	34.18%
FCF Margin	35.93%

Dividends & Yields

This stock pays an annual dividend of 1.09, which amounts to a dividend yield of 2.33%.

Dividend Per Share	1.09
Dividend Yield	2.33%
Dividend Growth (YoY)	-0.68%
Years of Dividend Growth	n/a
Payout Ratio	34.80%
Buyback Yield	7.79%
Shareholder Yield	10.12%
Earnings Yield	6.52%
FCF Yield	7.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:UTM has an Altman Z-Score of 34.91 and a Piotroski F-Score of 5.

Altman Z-Score	34.91
Piotroski F-Score	5